Caspary S, Keller-Stanislawski B, Huber T, Merz P G
Abteilung für Klinische Pharmakologie, Universitätsklinik Frankfurt, FRG.
Int J Clin Pharmacol Ther Toxicol. 1991 Mar;29(3):92-5.
Transdermal nicotine systems (Nicotinell 30) were applied daily to the skin of healthy nicotine-dependent smokers for 4 days. Blood samples were taken for the measurement of nicotine and cotinine in plasma using capillary gas chromatography with nitrogen detection. The plasma concentration-time profiles of nicotine and cotinine and the pharmacokinetic parameters cmax, tmax, AUC and the elimination half-life were determined under steady-state conditions. Nicotine levels after application of the 30 cm2 patch were in accord with published values for 10, 20 and 2 x 20 cm2 patches. The elimination half-life of nicotine after removal of the patch was longer than reported values obtained after i.v. application.
将透皮尼古丁系统(Nicotinell 30)每日应用于健康的尼古丁依赖吸烟者的皮肤,持续4天。采集血样,采用带氮检测的毛细管气相色谱法测定血浆中的尼古丁和可替宁。在稳态条件下测定尼古丁和可替宁的血浆浓度-时间曲线以及药代动力学参数cmax、tmax、AUC和消除半衰期。应用30平方厘米贴片后的尼古丁水平与已发表的10平方厘米、20平方厘米和2×20平方厘米贴片的值一致。去除贴片后尼古丁的消除半衰期比静脉注射后报道的值更长。